{"id":168,"date":"2021-02-04T12:10:26","date_gmt":"2021-02-04T12:10:26","guid":{"rendered":"https:\/\/ecrinm3.usal.es\/?page_id=168"},"modified":"2021-03-10T12:42:03","modified_gmt":"2021-03-10T12:42:03","slug":"professor-eugenio-santos","status":"publish","type":"page","link":"http:\/\/ecrinm3.usal.es\/?page_id=168","title":{"rendered":"Professor Eugenio Santos"},"content":{"rendered":"\n<div class=\"wp-block-media-text alignwide is-stacked-on-mobile\" style=\"grid-template-columns:27% auto\"><figure class=\"wp-block-media-text__media\"><img loading=\"lazy\" width=\"2000\" height=\"3000\" src=\"http:\/\/ecrinm3.usal.es\/wp-content\/uploads\/2021\/03\/Eugenio-Santos.jpg\" alt=\"\" class=\"wp-image-1245 size-full\"\/><\/figure><div class=\"wp-block-media-text__content\">\n<p><em><strong><em><strong>According to this proposal, his research team participates in WP1 (coordination and management), WP4 (Task 4.2), WP5 (Task 5.2) and WP6 (Data analysis, dissemination and exploitation of results), contributing expertise of his research group on analysis and characterization of cellular signalling pathways and transcriptomic patterns driven by canonical members of the RAS family of oncoproteins (HRAS, NRAS, KRAS) and their activators by guanine nucleotide exchange belonging to the GRF and SOS families (in particular GRF1, GRF2, SOS1 and SOS2).<\/strong><\/em><\/strong><\/em><\/p>\n\n\n\n<p>Professor Eugenio Santos is a Professor of Microbiology in the Department of Microbiology and Genetics at the University of Salamanca, Principal Investigator at the Cancer Research Centre of Salamanca<\/p>\n<\/div><\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>He holds a degree in Biology from the University of Salamanca (1975). After his dissertation, which he defended in Salamanca University with the extraordinary award in 1978, he moved to United States: first internship was in the Roche Institute of Molecular Biology, Nutley, Nueva Jersey (1978-1981), later he moved to the Laboratory of Cellular and Molecular Biology of the National Institutes of Health (NIH) \/ National Cancer Institute of Bethesda, in Maryland, where he was a Principal Investigator (1984-1999)<\/p>\n\n\n\n<p>Since his participation in the isolation and characterisation of the first human oncogene (H-ras), he has worked in different aspects of the structure, function and regulation of genes and proteins within the RAS family.<\/p>\n\n\n\n<p>Since 1999 he is the Director of the Cancer Research Centre of Salamanca<\/p>\n\n\n\n<p>He has supervised numerous doctoral thesis.<\/p>\n\n\n\n<p>Eugenio Santos investigates the molecular mechanisms of cancer and its malignant transformation, human oncogenes, as well as signal transduction process and development and cell proliferation control in eukaryotic cells.<\/p>\n\n\n\n<p>Among others, he has received plenty of awards and distinctions.<\/p>\n\n\n\n<p>1984 Monographic Prize by the Spanish Association Against Cancer (Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer).<\/p>\n\n\n\n<p>1986 I \u00abSevero Ochoa\u00bb Prize for Biomedical Research by Ferrer Foundation, Barcelona.9\u200b<\/p>\n\n\n\n<p>1995 Elected to the Editorial Academy, International Journal of Oncology and Oncology Reports.<\/p>\n\n\n\n<p>1996 Sientific and Technical Investigation Prize, (Premio de Investigaci\u00f3n Cient\u00edfica y T\u00e9cnica), Comunidad Castilla y Le\u00f3n, April 1996\u200b<\/p>\n\n\n\n<p>1999 National Prize for Cancer Investigation \u201cCiudad de Zamora\u201d. Scientific Foundation of Caja Rural. Zamora, November 1999<\/p>\n\n\n\n<p>2001 Full Member (Acad\u00e9mico de N\u00famero), the Spanish Medical and Surgical Academy, Madrid<\/p>\n\n\n\n<p>2003 Full Member (Acad\u00e9mico de N\u00famero), Royal Academy of Medicine of Salamanca<\/p>\n\n\n\n<p>2004 National coordinator, Cooperative Research Thematic Network (RETIC) of Cancer Research Centres, by the Carlos III Institute of Health of the Ministry of Health<\/p>\n\n\n\n<p>2003 Expert, National Committee for Biomedicine Programme, Ministry of Science and Technology.<\/p>\n\n\n\n<p>2003 Expert, Comprehensive Cancer Plan, Ministry of Health and Consumer policy.<\/p>\n\n\n\n<p>2003 Commandery of the Civil Order of Health, Health and Consumer policy<\/p>\n\n\n\n<p>2004 Scientific Board of Trustees at C\u00e1ncer del Centro Nacional de Investigaciones Oncol\u00f3gicas (Spanish National Cancer Research Centre) (Madrid), CSAT (Valencia), CIMAGO (Linha de Investiga\u00e7\u00e3o Cl\u00ednica e Interdisciplinar em Meio Ambiente, Gen\u00e9tica e Oncobiologia-) (Coimbra), IUOPA (The University Institute of Oncology of Asturias \u2013 Cajastur Social Programme) (Asturias), IDIBAPS, (he Bellvitge Biomedical Research Institute) IDIBELL (Barcelona) y AECC (Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer).<\/p>\n\n\n\n<p>2010 V National Oncology Prize by Echevarne\u200b Foundation<\/p>\n\n\n\n<p>He has published more than 100 scientific articles that have obtained more than 4300 quotes (ISI Science Citation Index)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>According to this proposal, his research team participates in WP1 (coordination and management), WP4 (Task 4.2), WP5 (Task 5.2) and WP6 (Data analysis, dissemination and exploitation of results), contributing expertise of his research group on analysis and characterization of cellular signalling pathways and transcriptomic patterns driven by canonical members of the RAS family of oncoproteins [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":109,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-fullwidth.php","meta":[],"_links":{"self":[{"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/pages\/168"}],"collection":[{"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=168"}],"version-history":[{"count":19,"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/pages\/168\/revisions"}],"predecessor-version":[{"id":1254,"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/pages\/168\/revisions\/1254"}],"up":[{"embeddable":true,"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=\/wp\/v2\/pages\/109"}],"wp:attachment":[{"href":"http:\/\/ecrinm3.usal.es\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}